ProVise Management Group, LLC Q2 2016 Filing

Filed August 2, 2016

Portfolio Value

$543.6B

Holdings

301

Report Date

Q2 2016

Filing Type

13F-HR

All Holdings (301 positions)

#StockSharesValue% PortfolioType
301
CPRXCATALYST PHARMACEUTICALS INC
19,000$13.0M0.00%
PreviousPage 4 of 4